Anal Cancer

Showing 1 - 25 of 113

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cervical Cancer, Anal Cancer, Penile Cancer Trial in College Park (Personalized Chatbot Intervention, Non-Personalized Chatbot

Recruiting
  • Cervical Cancer
  • +2 more
  • Personalized Chatbot Intervention
  • +2 more
  • College Park, Maryland
    University of Maryland, College Park (Online Survey-Experiment)
Jul 17, 2023

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Carcinoma of Vagina Trial in Shanghai (HRYZ-T101 Injection, Fludarabine

Not yet recruiting
  • Cervical Cancer
  • +5 more
  • HRYZ-T101 Injection
  • Fludarabine + Cyclophosphamide
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 17, 2023

Anal Cancer Trial in Gothenburg (Biopsies)

Not yet recruiting
  • Anal Cancer
  • Biopsies
  • Gothenburg, Sweden
    Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Jul 3, 2023

Anal Cancer Trial in Cincinnati (Radiation (reduced elective nodal dose (30.6 Gy), Capecitabine, Mitomycin c)

Not yet recruiting
  • Anal Cancer
  • Radiation (reduced elective nodal dose (30.6 Gy)
  • +2 more
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Jun 5, 2023

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma

Recruiting
  • Anal Cancer
  • Anal Squamous Intraepithelial Neoplasia
    • London, United Kingdom
      Imperial College London- Chelsea and Westminster NHS Foundation
    Apr 19, 2023

    Anal Cancer Risk In Women

    Recruiting
    • Anal Cancer
    • +4 more
    • Dual Pathology
    • London, United Kingdom
    • +1 more
    Apr 19, 2023

    Cervical Cancer, HPV Cancers, Anal Cancer Trial run by the NCI (PDS0101, M7824, NHS-IL12)

    Active, not recruiting
    • Cervical Cancer
    • +4 more
    • PDS0101
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

    Not yet recruiting
    • Cervical Cancer
    • +20 more
    • E7 TCR-T cells
    • New Brunswick, New Jersey
    • +1 more
    Jan 18, 2023

    Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

    Recruiting
    • Advanced Cancer
    • +24 more
    • pembrolizumab
    • Los Angeles, California
    • +21 more
    Jan 18, 2023

    HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

    Not yet recruiting
    • HPV-Associated Cervical Carcinoma
    • +16 more
    • Conditioning, E7 TCR-T cells, and aldesleukin
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 17, 2023

    Squamous Cell Lung Cancer, Vulvar Cancer, Penile Cancer Trial in France (pembrolizumab; vorinostat)

    Active, not recruiting
    • Squamous Cell Lung Cancer
    • +5 more
    • pembrolizumab; vorinostat
    • Angers, France
    • +13 more
    Jan 4, 2023

    ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION

    Not yet recruiting
    • Anal Cancer
    • Observational/Survery
    • Minneapolis, Minnesota
      University of Minnesota
    Nov 16, 2022

    NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +10 more
    • Singapore, Singapore
      Novartis Investigative Site
    Nov 16, 2022

    Human Papillomavirus in Young People Epidemiological Research 4

    Not yet recruiting
    • Human Papillomavirus Infection
    • +6 more
      • (no location specified)
      Oct 17, 2022

      Human Papillomavirus in Young People Epidemiological Research 3

      Not yet recruiting
      • Human Papillomavirus Infection
      • +6 more
        • (no location specified)
        Oct 17, 2022

        Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

        Recruiting
        • Adenocarcinoma
        • +75 more
        • Biomarker Testing (L)
        • +2 more
        • Idaho Falls, Idaho
        • +1 more
        Oct 18, 2022

        Anal Cancer Trial in Chicago, Houston (Practice Self-/Companion Exams, Control Arm)

        Recruiting
        • Anal Cancer
        • Practice Self-/Companion Exams
        • Control Arm
        • Chicago, Illinois
        • +3 more
        Oct 14, 2022

        Anal Cancer Trial in Worldwide (AMR B: HPV positive ctDNA guided imaging in follow-up)

        Not yet recruiting
        • Anal Cancer
        • AMR B: HPV positive ctDNA guided imaging in follow-up
        • Herlev, Capital Region Of Denmark, Denmark
        • +12 more
        Oct 5, 2022

        PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark

        Recruiting
        • Anal Cancer
          • Aarhus, Denmark
          • +2 more
          Oct 5, 2022

          Tool to Describe HIV-Related Cancer Burden and Patient

          Not yet recruiting
          • HIV-Associated Malignant Neoplasm
          • +7 more
          • Non-Interventional
          • Non-Interventional Follow-up
          • (no location specified)
          Aug 18, 2022

          Anal Cancer, Anal Carcinoma, Anal Squamous Cell Carcinoma Trial in Herlev (online adaptive radiotherapy)

          Recruiting
          • Anal Cancer
          • +2 more
          • online adaptive radiotherapy
          • Herlev, Denmark
            Oncology dept, Herlev and Gentofte Hospital
          Aug 2, 2022

          Anal Cancer Trial in United States (biological, drug, radiation)

          Completed
          • Anal Cancer
          • cetuximab
          • +3 more
          • Stanford, California
          • +124 more
          Jun 8, 2022

          Cervical Cancer, Anal Cancer, Head Neck Cancers Trial in Zhengzhou (Fludarabine + Cyclophosphamide, Interleukin-2, CRTE7A2-01

          Recruiting
          • Cervical Cancer
          • +2 more
          • Fludarabine + Cyclophosphamide
          • +2 more
          • Zhengzhou, Henan, China
            The First Affiliated Hospital of Zhengzhou University
          Jun 22, 2022